cervical ectopy
Conditions
Interventions
Group A with PRP will be applied topically.
Group B with PRP injected .
group C with silver nitrate
Sponsors
Sara Elsayed Mohammed PhD student
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: *Married sexually active females in the reproductive age (20-45) years. *Women with cervical ectopy symptomatic with vaginal discharge, postcoital bleeding, pelvic pain, recurrent cervicitis. *Women with cervical ectopy diagnosed by examination and colposcope and failed to respond to antibiotic treatment *Pap smear shows only inflammatory changes.
Exclusion criteria
Exclusion criteria: Subjects who did not provide consent. *Subjects having dysplastic or neoplastic cells on cervical smear test and colposcopy (CIN I - CIN II -CIN III or cervical cancer) *Subjects having other gynecologic disorders including uterus prolapse *Subjects who are pregnant or breast feeding or post-menopausal or on hormonal contraception. *Subjects who have high numbers of leucocytes (usually >30 per high power field) in the vaginal smear or have an active infection confirmed by culture and sensitivity. Subjects having platelet dysfunction (thrombocytopenia) or other hematological disorders *Subjects unwilling to return for follow-up visits *Subjects with associated mass lesions in the cervix. * Subjects who are immunocompromised (Diabetes mellitus – Systemic lupus erythematous)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To show the efficacy of topical versus intra-lesion injection of Platelet- rich plasma (PRP) in comparison to the application silver nitrate for the management of cervical ectopy. | — |
Secondary
| Measure | Time frame |
|---|---|
| The possible complications of each management technique. | — |
Countries
Egypt
Contacts
Public ContactMohamed Adel
Suez Canal University
Outcome results
None listed